We are live on
!
Find out more
CA
Cullinan Associates Portfolio holdings
AUM
$1.24B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
+1.46%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$615M
AUM Growth
-$265M
(-30%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-34.24%
Top 10 Holdings %
Top 10 Hldgs %
73.3%
Holding
97
New
9
Increased
13
Reduced
57
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$3.8M |
| 2 |
L3Harris
LHX
|
+$2.71M |
| 3 |
McKesson
MCK
|
+$2.6M |
| 4 |
UnitedHealth
UNH
|
+$2.21M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.4M |
| 2 |
United Parcel Service
UPS
|
+$25.2M |
| 3 |
Coca-Cola
KO
|
+$19M |
| 4 |
Walt Disney
DIS
|
+$8.27M |
| 5 |
Procter & Gamble
PG
|
+$7.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 56.11% |
| 2 | Energy | 10.64% |
| 3 | Healthcare | 10.54% |
| 4 | Industrials | 7.86% |
| 5 | Technology | 3.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
HP
HPQ
$23.5B
| $254K | 0.04% |
+22,590
| New | +$340K |
|
77
Alcoa
AA
$11.7B
| $195K | 0.03% |
10,404
-1,123
| -10% | -$36.8K |
|
78
Adobe
ADBE
$89.5B
| – | – |
-20,600
| Closed | -$1.35M |
|
79
Aegon
AEG
$13.5B
| – | – |
-26,195
| Closed | -$164K |
|
80
Allstate
ALL
$66.9B
| – | – |
-15,726
| Closed | -$890K |
|
81
Amgen
AMGN
$203B
| – | – |
-17,010
| Closed | -$2.1M |
|
82
Brown-Forman Class B
BF.B
$12B
| – | – |
-73,475
| Closed | -$2.11M |
|
83
Boston Scientific
BSX
$65.8B
| – | – |
-41,965
| Closed | -$567K |
|
84
Diageo
DEO
$46.2B
| – | – |
-20,426
| Closed | -$2.54M |
|
85
GSK
GSK
$103B
| – | – |
-30,537
| Closed | -$2.04M |
|
86
Halliburton
HAL
$27.9B
| – | – |
-12,600
| Closed | -$742K |
|
87
Occidental Petroleum
OXY
$57B
| – | – |
-17,744
| Closed | -$1.62M |
|
88
Sypris Solutions
SYPR
$43.7M
| – | – |
-18,000
| Closed | -$50K |
|
89
UBS Group
UBS
$170B
| – | – |
-179,542
| Closed | -$3.72M |
|
90
VF Corp
VFC
$6.68B
| – | – |
-124,866
| Closed | -$7.28M |
|
|
MXIM
91
DELISTED
Maxim Integrated Products
MXIM
| – | – |
-155,429
| Closed | -$5.15M |
|
|
KKD
92
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| – | – |
-20,000
| Closed | -$355K |
|
|
MSS
93
DELISTED
MILESTONE SCIENTIFIC INC (NEW)
MSS
| – | – |
-24,380
| Closed | -$760K |
|
Similar funds
WTA
MP
GX
HCA
NHAS
CCA
FLII
IC
Cullinan Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Cullinan Associates held 97 positions worth $615M, down 30% from $879M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Cullinan Associates withdrew a net $210M in Q2 2014, closing 17 positions and reducing 57 holdings. Its most notable exit was VF Corp, an estimated $7.28M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 56% of assets, up from 45% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Cullinan Associates opened a new position in Raytheon Company worth $2.59M.
- Cullinan Associates's largest Q2 2014 buy was Raytheon Company: 39,151 shares worth $2.59M.
- Cullinan Associates added most to Xilinx Inc in Q2 2014, an estimated $1.66M increase.
- Cullinan Associates's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $43.4M.
- Cullinan Associates fully exited VF Corp in Q2 2014, selling an estimated $7.28M.
- Cullinan Associates's ten largest holdings make up 73% of its $615M portfolio in Q2 2014.
- Cullinan Associates opened 9 new positions and closed 17 in Q2 2014.
- Cullinan Associates's portfolio value fell 30% quarter-over-quarter to $615M.
Based on Cullinan Associates's 13F filing for Q2 2014, filed 15 Aug 2014.